DNA graphic

Financials

The following is an overview of the Lupus Research Alliance’s income and expenditures for the fiscal year ended December 31, 2019.

Revenue & Other Support:
Contributions $17,673,622
Other Support $ 5,417,259
Total Revenue & Other Support: $23,090,881

Program Expenditures:
Research $ 11,771,155
Scientific programs $ 8,746,496
Public policy $ 846,235
Total Program Expenditures: $21,363,886

Administration Expenditures: $2,129,277*
Fundraising Expenditures: $3,029,588*

End of Year Net Asset Balance: $44,770,201

*The LRA’s Supporting Services are covered by donations from its Board of Directors.

As of December 31, 2019, The Lupus Research Alliance has unrestricted financial reserves of approximately $39 million or about 1.3 times its most recent annual expenses, which totaled approximately $27 million. The majority of the $39 million is being held in a board designated endowment in order for the organization to have funds available for special research projects and is designated solely for lupus research.

Click on the following for more information

Read about the programs that support medical breakthroughs